Skip to main content

Finepoint Capital LP

SEC CIK
0001608126
Latest filing
Aug 13, 2026

Holdings in Q4 2025

Holdings as of Dec 31, 2025, filed Feb 13, 2026. Long positions only; changes compare share counts with Q3 2025.

Institution overview
Positions
7
0 vs. Q3 2025
Portfolio value
$532.8M
−$10.2M (−1.9%) vs. Q3 2025
Filed
Feb 13, 2026
SEC
Holdings of Finepoint Capital LP in Q4 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
QXOQXO, Inc.COM NEW21,177,415$408.5M76.7%−1,118,200−5.0%ReducedHistory
RXORXO, Inc.COMMON STOCK9,388,789$118.7M22.3%+2,121,950+29.2%AddedHistory
SLDBSolid Biosciences Inc.COM NEW961,251$5.42M1.0%00.0%UnchangedHistory
ANNAAleAnna, Inc.COM CL A27,717$79.0K<0.1%00.0%UnchangedHistory
ANNAWAleAnna, Inc.*W EXP 12/13/202490,000$69.3K<0.1%00.0%UnchangedHistory
MNYWWMoneyHero Ltd*W EXP 09/13/202895,000$38.3K<0.1%00.0%UnchangedHistory
CLDICalidi Biotherapeutics, Inc.COM1,042$1.22K<0.1%00.0%UnchangedHistory

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Finepoint Capital LP in Q4 2025
SecurityClassPutsCalls
SPYSPDR S&P 500 ETF TrustETF$1.07B–
iShares Russell 2000 ETF464287655ETF$398.0M–